Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

FLORHAM PARK, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to participate in the following upcoming investor conferences in September:

2026 Cantor Global Healthcare Conference in New York, NY Date: Wednesday, September 9, 2026 Fireside Chat: 10:55 am EDT Management to participate in one-on-one meetings throughout the conference